Skip Navigation
Skip to contents



10 results

Multiple Cardiac Metastases from a Nonfunctioning Pancreatic Neuroendocrine Tumor

Choi YH, Han HS, Lim SN, Lee SY, Koo JH, Lee OJ, Lee KH, Kim ST

  • Cancer Res Treat.
  • 2013 Jun;45(2):150-154.
Pancreatic neuroendocrine tumors (pNETs) are rare neoplasms, which most commonly metastasize to the liver. However, intrathoracic metastases from pNETs are encountered infrequently. This report describes a case of nonfunctioning pNET...
Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma

Lim S, Han J, Park KH, Jung WJ, Lee YK, Choi A, Kim YJ, Lee JC, Choi HJ

  • Cancer Res Treat.
  • 2013 Jun;45(2):145-149.
Humoral hypercalcemia of malignancy (HHM) is rarely associated with cholangiocarcinoma (CC), and represents dismal prognosis. A 63-year-old male was admitted for evaluation of an intrahepatic mass. He was diagnosed with...
RASSF1A Suppresses Cell Migration through Inactivation of HDAC6 and Increase of Acetylated alpha-Tubulin

Jung HY, Jung JS, Whang YM, Kim YH

  • Cancer Res Treat.
  • 2013 Jun;45(2):134-144.
PURPOSE: The RAS association domain family protein 1 (RASSF1) has been implicated in a tumor-suppressive function through the induction of acetylated alpha-tubulin and modulation of cell migration. However, the mechanisms...
Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line

Yoon SG, Cheong HJ, Kim SJ, Kim KH, Lee SC, Lee N, Park HS, Won JH

  • Cancer Res Treat.
  • 2013 Jun;45(2):126-133.
PURPOSE: Leukemic promyelocytes have the unique ability to undergo differentiation after exposure to retinoic acid and both differentiation and apoptosis after exposure to arsenic trioxide (ATO). Recent studies have shown...
Expression of Transforming Growth Factor beta1 and E-Cadherin Proteins in Pulmonary Adenocarcinoma: Its Significance in Tumor Progression

Kim CH, Park SY, Yoo J

  • Cancer Res Treat.
  • 2013 Jun;45(2):118-125.
PURPOSE: This study was conducted in order to investigate the significance of transforming growth factor beta1 (TGFbeta1) and E-cadherin proteins in tumor progression of lung adenocarcinoma and to evaluate their...
Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement

Kang BW, Moon JH, Chae YS, Lee SJ, Kim JG, Kim YK, Lee JJ, Yang DH, Kim HJ, Kim JY, Do YR, Park KU, Song HS, Kwon KY, Kim MK, Lee KH, Hyun MS, Ryoo HM, Bae SH, Kim H, Sohn SK

  • Cancer Res Treat.
  • 2013 Jun;45(2):112-117.
PURPOSE: We investigated the clinical outcome of bone marrow (BM) involvement in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based therapy. MATERIALS AND METHODS: A total of 567 consecutive...
Which Patients Might Benefit from Postmastectomy Radiotherapy in Breast Cancer Patients with T1-2 Tumor and 1-3 Axillary Lymph Nodes Metastasis?

Kong M, Hong SE

  • Cancer Res Treat.
  • 2013 Jun;45(2):103-111.
PURPOSE: This study compared the clinical outcomes of T1-2N1 breast cancer patients with and without postmastectomy radiotherapy (PMRT). Risk factors for loco-regional recurrence (LRR) were identified in order to define...
Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis

Lee DS, Kang JH, Lee CG, Kim SJ, Choi YJ, Lee KY, Kim YS

  • Cancer Res Treat.
  • 2013 Jun;45(2):95-102.
PURPOSE: A number of factors related to overall survival (OS) have been addressed in advanced non-small cell lung cancer (NSCLC). This study was conducted to determine the impact of whole-body...
Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey, 2004-2012

Suh M, Choi KS, Lee YY, Jun JK

  • Cancer Res Treat.
  • 2013 Jun;45(2):86-94.
PURPOSE: The Korean National Cancer Screening Survey (KNCSS), a nationwide, annual cross-sectional survey, has been conducted since 2004. The current study was conducted in order to report on trends in...
Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Lee JC, Jang SH, Lee KY, Kim YC

  • Cancer Res Treat.
  • 2013 Jun;45(2):79-85.
Since the first description of non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation as a distinct clinical entity, studies have proved EGFR tyrosine kinase inhibitors...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: